Department of Pathology, Stanford University School of Medicine, Stanford, California 94305,1 Institute of Genetic Medicine, Cornell University Weill Medical School, New York, New York 10021,2 Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota 55905,3 Deutsches Krebsforchungszentrum, Angewandte Tumorvirologie, 69120 Heidelberg, Germany,4 Department of Genetics, St. Jude Children's Research Hospital, Memphis, Tennessee 381055
Received 31 October 2003/ Returned for modification 8 December 2003/ Accepted 18 March 2004
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Biochemical studies have demonstrated that Pbx proteins interact with a subset of Hox proteins to enhance their DNA binding affinities and specificities (6-9, 16, 19, 24-26, 37, 38). Pbx proteins also heterodimerize with the Meis/Prep subfamily of TALE-class homeodomain proteins (4, 8, 14) to form trimeric complexes with Hox proteins on appropriate DNA sites (3, 4, 12, 33) that regulate developmental gene expression. Pbx proteins are highly similar to each other and share extensive sequence identity within and flanking their DNA binding homeodomains. Additional isoforms of mammalian Pbx proteins arise from differential splicing of Pbx transcripts to yield high-molecular-weight (MW) (Pbx1a, Pbx2, Pbx3a, and Pbx4) and low-MW (Pbx1b and Pbx3b) forms of the respective proteins (22, 40). Although the DNA binding properties of Pbx proteins appear similar in vitro, the transcriptional effector properties of various isoforms can be distinguished on the basis of differential recruitment of transcriptional cofactors (2).
In contrast to their well-characterized roles as transcription factors, the differential contributions of Pbx proteins during mammalian development and organogenesis have not been fully determined. To assess their functional roles in vivo and their possible overlapping and unique contributions, we have generated and characterized mice deficient for each of the Pbx1, -2, and -3 proteins. Our previous studies demonstrated that Pbx1 and Pbx3 have unique, essential functions required for embryonic development and postnatal survival, respectively. Pbx1-deficient embryos die at gestational day 15 or 16 with severe hypoplasia or aplasia of multiple organs (15, 32, 34, 36), as well as homeotic transformation (36) and hematopoietic abnormalities (11). Mice deficient for Pbx3 develop to term but die within a few hours of birth due to central respiratory failure (J. Rhee, A. Arata, L. Selleri, Y. Jacobs, S. Arata, H. Onimaru, and M. Cleary, submitted for publication). In this study, we demonstrated that, despite widespread embryonic expression, Pbx2 is not an essential gene, whose loss does not affect normal development, organogenesis, fertility, hematopoiesis, or immune function, likely due to redundancy with the related Pbx family members.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
Western blot analysis.
Embryonic tissues (E17), thymocytes, or adult bone marrow cells were lysed in 2x SDS sample buffer following homogenization using established procedures (12). Proteins were subjected to SDS-polyacrylamide gel electrophoresis and immobilized on nitrocellulose filters following electrophoretic transfer. Filters were probed with a murine monoclonal antibody that recognizes all three Pbx high-MW isoforms (
-PbxL) or monoclonal antibodies specific for Pbx1a or Pbx3a. A Pbx2 affinity-purified rabbit polyclonal antibody raised against a peptide mapping at the amino terminus of Pbx2 was also used (Santa Cruz Biotechnology, Inc.). Immune complexes were detected by using a horseradish peroxidase-conjugated secondary antibody and an enhanced luminescence system (ECL; Amersham Pharmacia Biotech, Inc., Piscataway, N.J.).
Histology. For histological analysis, embryos were fixed in formalin and embedded in paraffin for sectioning using standard procedures (35). Sections of 5 µm thickness were stained with hematoxylin and eosin, mounted in distrene plasticizer xylene, and photographed.
Skeletal preparations. Differential staining of cartilage and bone in whole mouse embryos (E16) and newborn mice was visualized with alcian blue and alizarin red (10, 21)
Whole-mount and section in situ hybridizations. Whole-mount in situ hybridizations were performed on embryos at E9.5 and E10.5 as previously described (43). In situ hybridizations were performed on frozen sections, generated from wild-type (wt) embryos at E13.5 and E15.5, as previously described (43). Single-stranded sense and antisense riboprobes specific for the Pbx2 cDNA were generated and hybridized to frozen sections containing all developing organs in order to establish Pbx2 expression patterns in later stages of murine development. The Pbx2 hybridization probe was composed of approximately 650 bp of 3' UTR as described above. Probes were labeled with digoxigenin, using standard procedures (42). Images were obtained using an Olympus BX41 compound light microscope and digital camera or an Olympus SZX12 dissection microscope.
Real-time quantitative RT-PCR. For reverse transcription-PCR (RT-PCR) total RNA was isolated from E17.5 tissues by using Trizol reagent (Gibco BRL) and treated with DNase Treatment and Removal Reagent (DNA-free; Ambion). RNA was reverse transcribed by using the High Capacity cDNA Archive kit (Applied Biosystems, Foster City, Calif.), using random primers for initiating cDNA synthesis. TaqMan real-time quantitative PCR assays were performed on a Perkin-Elmer ABI PRISM 7700 sequence detection system, using SDS version 1.9 software (Applied Biosystems). Specific primers and fluorogenic TaqMan probes were custom designed using the Assay by Design Service (Applied Biosystems). Primers, probes, and PCR conditions are available upon request.
Hematologic studies. Blood (50 to 100 µl) from the tail vein was collected in an EDTA-coated tube, and automated blood counts were performed using a Coulter cytometer.
Immunological studies. Freshly isolated cells from bone marrow and thymus were stained for four-color analysis, and the fluorescence was analyzed by using a dual-laser FACS Vantage system (Becton Dickinson Immunocytometry Systems, Mountain View, Calif.) with a four-decade logarithmic amplifier. Dead cells were detected by staining with propidium iodide (1 µg/ml) and gated out electronically. Residual erythrocytes were also gated out electronically. All antibodies were purchased from BD Pharmingen (San Diego, Calif.). Specificities of antibodies were as follows: phycoerythrin-conjugated RM4-5 (anti-CD4), biotinylated 53-6.7 (anti-CD8a), fluorescein isothiocyanate-conjugated S7 (anti-CD43), and allophycocyanin-conjugated RA3-6B2 (anti-B220).
Mice were immunized by intraperitoneal injection of 100 µg of 2,4-dinitrophenol (DNP) conjugated to keyhole limpet hemocyanin (DNP-KLH) with complete Freund's adjuvant, as described previously (31). The titers of anti-DNP antibodies were measured by enzyme-linked immunosorbent assay using DNP-conjugated bovine albumin (DNP-albumin) as the capture antigen, alkaline phosphatase-conjugated rabbit anti-mouse immunoglobulin G (IgG) or IgM as the secondary antibody, and Sigma Fast p-nitrophenyl phosphate as the substrate for alkaline phosphatase. Absorbances (405 nm) of pre- and postimmune sera were compared to monitor immune responses against the hapten.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
|
In sum, in early mouse development Pbx2 expression is widespread, comparable to the ubiquitous Pbx2 expression during the first hours of zebra fish development (41). Later in mouse development, Pbx2 expression becomes more restricted and mostly preponderant in epithelial and neural tissues, comparable to expression patterns of the Drosophila homolog Exd (29). Conversely, Pbx2 is expressed at very low levels or is undetectable in the mesenchymal components of most tissues and organ systems, in contrast to Pbx1, which is highly expressed in mesenchymal and mesodermal cells (35).
Pbx2 is not essential for fetal and postnatal survival. Mice with targeted disruption of Pbx2 were generated to determine whether the wide expression of Pbx2 during murine embryogenesis reflected a major role for its encoded protein in development. A null allele of the endogenous mouse Pbx2 gene was created by deletion of the entire third exon and insertion of a neomycin resistance gene through homologous recombination in ES cells (Fig. 2A). Exon 3 was chosen for targeting since: (i) it is the largest Pbx2 5' exon (other than exon 1), whose disruption allows a truncation of Pbx2 immediately downstream of the initiating methionine to minimize possible expression of a truncated protein with dominant-negative properties; (ii) it lacks a unit number of codons, thereby minimizing the generation of a protein product with an in-frame deletion retaining partial or complete function, due to splicing around the targeted exon; and (iii) it codes for a portion of Pbx2 that is highly conserved in humans, mice, and flies. Exon 1 was not targeted since no information was available regarding possible alternative initiation sites downstream of exon 1, within the first intron. Overall, the above-described strategy proved successful, as a complete knockout of Pbx2 was obtained (Fig. 2).
The expected wt and mutated Pbx2 alleles were observed by Southern blot analysis of DNA extracted from targeted ES cell lines (results not shown) and mouse tissues (Fig. 2B). Western blot analysis of postnatal thymocytes and bone marrow cells showed that homozygous mutant mice did not produce Pbx2 protein, the only high-MW-isoform Pbx protein detectable in these tissues (Fig. 2C). Furthermore, Western blot analysis of fetal livers at E16.5 with a Pbx2-specific antibody raised against a peptide mapping at the amino terminus of Pbx2 clearly demonstrated that homozygous mutant mice did not produce full-length (50 kDa) or truncated forms of Pbx2 (Fig. 2D). Northern blot analysis was performed to exclude the possibility that a mutant Pbx2 protein, not detectable by Western blot analysis, might be produced from an altered transcript encoded by the targeted Pbx2 gene. This analysis demonstrated the absence of either full-length or truncated Pbx2 transcripts in Pbx2/ embryos (Fig. 2E). Pbx2/ mice were viable, with binomial proportion analysis showing no deviations from a 2:1 ratio of heterozygote to wt or heterozygote to homozygous mutant (data not shown). The sizes and body weights of Pbx2/ mice were indistinguishable from those of their wt littermates (18.68 ± 1.25 g and 18.35 ± 1.34 g, respectively), as was their longevity and fertility (data not shown). The normal survival of Pbx2/ mice suggested that Pbx2 is not solely or primarily responsible for any processes that are critical for development or survival.
Pbx2 is not essential for organogenesis. Although lack of Pbx2 was compatible with life, this did not rule out possible subtle effects on organ structure. Major internal organs of Pbx2/ newborn mice and their wt littermates were examined grossly and by histology. No structural or morphological abnormalities of internal organs were observed in Pbx2/ mice (lung, liver, spleen, and kidney of wt and Pbx2/ mice are shown in Fig. 3). Furthermore, cartilage/skeletal preparations of Pbx2/ embryos and newborn mice showed neither gross nor subtle defects in cartilaginous and skeletal development (data not shown). These data demonstrate that lack of Pbx2 expression has no detectable effect on the morphogenesis of organs in which it is normally expressed.
|
-PbxL) that recognizes a Pbx2 epitope shared with the high-MW isoforms of Pbx1 and Pbx3 (Pbx1a and Pbx3a, respectively) but not present in the low-MW isoforms Pbx1b or Pbx3b (Pbx2 has no low-MW isoform). In most tissues examined from embryos at E17.5, there were no differences in the abundance of the high-MW-isoform Pbx proteins in Pbx2/ embryos as compared to wt embryos (Fig. 4A). A modest decrease was observed in fetal thymus, brain, and liver (Fig. 4A). The general lack of (or minimal) decrease in Pbx proteins detected with this antibody in tissues of Pbx2/ embryos suggested that Pbx2 is not the preponderant Pbx protein expressed in these tissues during embryogenesis. Furthermore, tissues and organs such as the developing brain, where Pbx2 is highly expressed, as demonstrated by in situ hybridization (Fig. 1), were not affected either morphologically or functionally by its loss. Quantitative real-time RT-PCR showed that transcripts for other high-MW Pbx isoforms (Pbx1a and Pbx3a) were expressed in developing brain and other tissues (Fig. 4B and C), but there was no evidence of compensatory increases in their levels in Pbx2/ compared to wt embryos. Taken together, these observations suggested that normal organ development and survival of Pbx2/ mice is likely to result from functional compensation by other Pbx proteins. Interestingly, it has been reported that in zebra fish the Pbx genes are functionally equivalent in that each one, when overexpressed, can efficiently rescue the lazarus/Pbx4 mutant phenotype (41).
|
|
|
Two models for mammalian Pbx protein function can be envisioned for conceptualizing the role of multiple Pbx isoforms and the divergent phenotypes induced by their absence. In a quantitative model, the various Pbx protein isoforms may be largely redundant, but with a requirement to maintain a critical threshold of Pbx protein concentration, regardless of isotype, necessary for normal development. This scenario would be comparable to Pbx function in zebra fish, where the Pbx proteins are functionally equivalent (41) and is also supported by preliminary results indicating that Pbx1/Pbx2+/ compound mutant embryos die in utero at E13.5, earlier than Pbx1/ embryos, which succumb at E15/16 (T. Capellini and L. Selleri, unpublished observations). Since our immunoblot analyses indicated that Pbx2 does not seem to be the preponderant Pbx protein in most tissues during embryonic development, its absence would not substantially reduce the total Pbx protein levels below the necessary threshold, thus accounting for the lack of measurable phenotypes. Alternatively, in a qualitative model, various Pbx isoforms (high versus low MW) may display different functional properties, consistent with in vitro biochemical studies of their divergent transcriptional effector properties (2). However, our analyses indicate that Pbx2 null mice lack detectable phenotypes attributable to deficiencies in tissues (thymus and adult bone marrow) that express Pbx2 as the only high-MW Pbx isoform protein. Since these tissues also express low-MW Pbx isoforms, such as Pbx1b, they may be able to functionally replace Pbx2. The alternative possibility that Pbx protein function is simply not required for postnatal hematopoietic and immune function has not been conclusively ruled out since Pbx1- and Pbx3-deficient mice die in utero or in the immediate postnatal period, respectively (Rhee et al., submitted; 36). Our results are most consistent with a quantitative model of mammalian Pbx protein function, but elucidation of the potential interrelationships and overlapping functions of Pbx family proteins in different developmental pathways will require detailed characterization of various organ systems in compound null mice.
| ACKNOWLEDGMENTS |
|---|
These studies were supported by grants to M.L.C. from the National Institutes of Health (CA42971, CA70704, and CA90735) and to L.S. from the March of Dimes and Birth Defects Foundation (6-FY03-071) and the National Institutes of Health (HD043997-01 A1).
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Asahara, H., S. Dutta, H. Y. Kao, R. M. Evans, and M. Montminy. 1999. Pbx-Hox heterodimers recruit coactivator-corepressor complexes in an isoform-specific manner. Mol. Cell. Biol. 19:8219-8225.
3. Berthelsen, J., C. Kilstrup-Nielsen, F. Blasi, F. Mavilio, and V. Zappavigna. 1999. The subcellular localization of PBX1 and EXD proteins depends on nuclear import and export signals and is modulated by association with PREP1 and HTH. Genes Dev. 13:946-953.
4. Berthelsen, J., V. Zappavigna, E. Ferretti, F. Mavilio, and F. Blasi. 1998. The novel homeoprotein Prep1 modulates Pbx-Hox protein cooperativity. EMBO J. 17:1434-1445.[CrossRef][Medline]
5. Burglin, T. R., and G. Ruvkun. 1992. New motif in PBX genes. Nat. Genet. 1:319-320.[CrossRef][Medline]
6. Chan, S. K., L. Jaffe, M. Capovilla, J. Botas, and R. S. Mann. 1994. The DNA binding specificity of Ultrabithorax is modulated by cooperative interactions with extradenticle, another homeoprotein. Cell 78:603-615.[CrossRef][Medline]
7. Chang, C. P., L. Brocchieri, W. F. Shen, C. Largman, and M. L. Cleary. 1996. Pbx modulation of Hox homeodomain amino-terminal arms establishes different DNA-binding specificities across the Hox locus. Mol. Cell. Biol. 16:1734-1745.[Abstract]
8. Chang, C. P., Y. Jacobs, T. Nakamura, N. A. Jenkins, N. G. Copeland, and M. L. Cleary. 1997. Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins. Mol. Cell. Biol. 17:5679-5687.[Abstract]
9. Chang, C. P., W. F. Shen, S. Rozenfeld, H. J. Lawrence, C. Largman, and M. L. Cleary. 1995. Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. Genes Dev. 9:663-674.
10. Depew, M. J., J. K. Liu, J. E. Long, R. Presley, J. J. Meneses, R. A. Pedersen, and J. L. Rubenstein. 1999. Dlx5 regulates regional development of the branchial arches and sensory capsules. Development 126:3831-3846.[Abstract]
11. DiMartino, J. F., L. Selleri, D. Traver, M. T. Firpo, J. Rhee, R. Warnke, S. O'Gorman, I. L. Weissman, and M. L. Cleary. 2001. The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver. Blood 98:618-626.
12. Jacobs, Y., C. A. Schnabel, and M. L. Cleary. 1999. Trimeric association of Hox and TALE homeodomain proteins mediates Hoxb2 hindbrain enhancer activity. Mol. Cell. Biol. 19:5134-5142.
13. Kamps, M. P., C. Murre, X. H. Sun, and D. Baltimore. 1990. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 60:547-555.[CrossRef][Medline]
14. Kilstrup-Nielsen, C., M. Alessio, and V. Zappavigna. 2003. PBX1 nuclear export is regulated independently of PBX-MEINOX interaction by PKA phosphorylation of the PBC-B domain. EMBO J. 22:89-99.[CrossRef][Medline]
15. Kim, S. K., L. Selleri, J. S. Lee, A. Y. Zhang, X. Gu, Y. Jacobs, and M. L. Cleary. 2002. Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus. Nat. Genet. 30:430-435.[CrossRef][Medline]
16. Knoepfler, P. S., and M. P. Kamps. 1995. The pentapeptide motif of Hox proteins is required for cooperative DNA binding with Pbx1, physically contacts Pbx1, and enhances DNA binding by Pbx1. Mol. Cell. Biol. 15:5811-5819.[Abstract]
17. Krumlauf, R. 1994. Hox genes in vertebrate development. Cell 78:191-201.[CrossRef][Medline]
18. Lau, M. M., C. E. Stewart, Z. Liu, H. Bhatt, P. Rotwein, and C. L. Stewart. 1994. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev. 8:2953-2963.
19. Lu, Q., P. S. Knoepfler, J. Scheele, D. D. Wright, and M. P. Kamps. 1995. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes. Mol. Cell. Biol. 15:3786-3795.[Abstract]
20. Mann, R. S., and M. Affolter. 1998. Hox proteins meet more partners. Curr. Opin. Genet. Dev. 8:423-429.[CrossRef][Medline]
21. McLeod, M. J. 1980. Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology 22:299-301.[CrossRef][Medline]
22. Monica, K., N. Galili, J. Nourse, D. Saltman, and M. L. Cleary. 1991. PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1. Mol. Cell. Biol. 11:6149-6157.
23. Nourse, J., J. D. Mellentin, N. Galili, J. Wilkinson, E. Stanbridge, S. D. Smith, and M. L. Cleary. 1990. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60:535-545.[CrossRef][Medline]
24. Peers, B., S. Sharma, T. Johnson, M. Kamps, and M. Montminy. 1995. The pancreatic islet factor STF-1 binds cooperatively with Pbx to a regulatory element in the somatostatin promoter: importance of the FPWMK motif and of the homeodomain. Mol. Cell. Biol. 15:7091-7097.[Abstract]
25. Peltenburg, L. T., and C. Murre. 1996. Engrailed and Hox homeodomain proteins contain a related Pbx interaction motif that recognizes a common structure present in Pbx. EMBO J. 15:3385-3393.[Medline]
26. Phelan, M. L., I. Rambaldi, and M. S. Featherstone. 1995. Cooperative interactions between HOX and PBX proteins mediated by a conserved peptide motif. Mol. Cell. Biol. 15:3989-3997.[Abstract]
27. Popperl, H., M. Bienz, M. Studer, S. K. Chan, S. Aparicio, S. Brenner, R. S. Mann, and R. Krumlauf. 1995. Segmental expression of Hoxb-1 is controlled by a highly conserved autoregulatory loop dependent upon exd/pbx. Cell 81:1031-1042.[CrossRef][Medline]
28. Popperl, H., H. Rikhof, H. Chang, P. Haffter, C. B. Kimmel, and C. B. Moens. 2000. Lazarus is a novel pbx gene that globally mediates hox gene function in zebrafish. Mol. Cell 6:255-267.[CrossRef][Medline]
29. Rauskolb, C., M. Peifer, and E. Wieschaus. 1993. extradenticle, a regulator of homeotic gene activity, is a homolog of the homeobox-containing human proto-oncogene pbx1. Cell 74:1101-1112.[CrossRef][Medline]
30. Rauskolb, C., and E. Wieschaus. 1994. Coordinate regulation of downstream genes by extradenticle and the homeotic selector proteins. EMBO J. 13:3561-3569.[Medline]
31. Sato, S., D. A. Steeber, and T. F. Tedder. 1995. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. USA 92:11558-11562.
32. Schnabel, C. A., R. E. Godin, and M. L. Cleary. 2003. Pbx1 regulates nephrogenesis and ureteric branching in the developing kidney. Dev. Biol. 254:262-276.[CrossRef][Medline]
33. Schnabel, C. A., Y. Jacobs, and M. L. Cleary. 2000. HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis. Oncogene 19:608-616.[CrossRef][Medline]
34. Schnabel, C. A., L. Selleri, and M. L. Cleary. 2003. Pbx1 is essential for adrenal development and urogenital differentiation. Genesis 37:123-130.[CrossRef][Medline]
35. Schnabel, C. A., L. Selleri, Y. Jacobs, R. Warnke, and M. L. Cleary. 2001. Expression of Pbx1b during mammalian organogenesis. Mech. Dev. 100:131-135.[CrossRef][Medline]
36. Selleri, L., M. J. Depew, Y. Jacobs, S. K. Chanda, K. Y. Tsang, K. S. Cheah, J. L. Rubenstein, S. O'Gorman, and M. L. Cleary. 2001. Requirement for Pbx1 in skeletal patterning and programming chondrocyte proliferation and differentiation. Development 128:3543-3557.
37. Shen, W. F., C. P. Chang, S. Rozenfeld, G. Sauvageau, R. K. Humphries, M. Lu, H. J. Lawrence, M. L. Cleary, and C. Largman. 1996. Hox homeodomain proteins exhibit selective complex stabilities with Pbx and DNA. Nucleic Acids Res. 24:898-906.
38. van Dijk, M. A., and C. Murre. 1994. extradenticle raises the DNA binding specificity of homeotic selector gene products. Cell 78:617-624.[CrossRef][Medline]
39. Vlachakis, N., D. R. Ellstrom, and C. G. Sagerstrom. 2000. A novel pbx family member expressed during early zebrafish embryogenesis forms trimeric complexes with Meis3 and Hoxb1b. Dev. Dyn. 217:109-119.[CrossRef][Medline]
40. Wagner, K., A. Mincheva, B. Korn, P. Lichter, and H. Popperl. 2001. Pbx4, a new Pbx family member on mouse chromosome 8, is expressed during spermatogenesis. Mech. Dev. 103:127-131.[CrossRef][Medline]
41. Waskiewicz, A. J., H. A. Rikhof, and C. B. Moens. 2002. Eliminating zebrafish pbx proteins reveals a hindbrain ground state. Dev. Cell 3:723-733.[CrossRef][Medline]
42. Wilkinson, D. G. 1995. RNA detection using non-radioactive in situ hybridization. Curr. Opin. Biotechnol. 6:20-23.[CrossRef][Medline]
43. Wilkinson, D. G., and M. A. Nieto. 1993. Detection of messenger RNA by in situ hybridization to tissue sections and whole mounts. Methods Enzymol. 225:361-373.[Medline]
44. Wilson, D. S., and C. Desplan. 1995. Homeodomain proteins. Cooperating to be different. Curr. Biol. 5:32-34.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|